Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Predementia Brain Changes in Progranulin Mutation: A Systematic Review of Neuroimaging Evidence.

Alexander C, Pisner D, Jacova C.

Dement Geriatr Cogn Disord. 2019;47(1-2):1-18. doi: 10.1159/000494968. Epub 2019 Jan 10.

2.

Older Adults' Attitudes towards Cognitive Testing: Moving towards Person-Centeredness.

Wong S, Jacova C.

Dement Geriatr Cogn Dis Extra. 2018 Oct 9;8(3):348-359. doi: 10.1159/000493464. eCollection 2018 Sep-Dec.

3.

Quantitative assessment of field strength, total intracranial volume, sex, and age effects on the goodness of harmonization for volumetric analysis on the ADNI database.

Ma D, Popuri K, Bhalla M, Sangha O, Lu D, Cao J, Jacova C, Wang L, Beg MF; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2019 Apr 1;40(5):1507-1527. doi: 10.1002/hbm.24463. Epub 2018 Nov 15.

PMID:
30431208
4.

The Impact of Covert Lacunar Infarcts and White Matter Hyperintensities on Cognitive and Motor Outcomes After Stroke.

Auriat AM, Ferris JK, Peters S, Ramirez J, Black SE, Jacova C, Boyd LA.

J Stroke Cerebrovasc Dis. 2019 Feb;28(2):381-388. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.009. Epub 2018 Nov 5.

PMID:
30409743
5.

Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers.

Popuri K, Dowds E, Beg MF, Balachandar R, Bhalla M, Jacova C, Buller A, Slack P, Sengdy P, Rademakers R, Wittenberg D, Feldman HH, Mackenzie IR, Hsiung GR.

Neuroimage Clin. 2018 Feb 17;18:591-598. doi: 10.1016/j.nicl.2018.02.017. eCollection 2018.

6.

Neuropsychological Performance Patterns of Adult ADHD Subtypes.

LeRoy A, Jacova C, Young C.

J Atten Disord. 2019 Aug;23(10):1136-1147. doi: 10.1177/1087054718773927. Epub 2018 May 17.

PMID:
29771179
7.

Decreased Prefrontal Activation during Matrix Reasoning in Predementia Progranulin Mutation Carriers.

Alexander C, Zeithamova D, Hsiung GR, Mackenzie IR, Jacova C.

J Alzheimers Dis. 2018;62(2):583-589. doi: 10.3233/JAD-170716.

PMID:
29480174
8.

Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial.

Barha CK, Hsiung GR, Best JR, Davis JC, Eng JJ, Jacova C, Lee PE, Munkacsy M, Cheung W, Liu-Ambrose T.

J Alzheimers Dis. 2017;60(4):1397-1410. doi: 10.3233/JAD-170221.

PMID:
29036816
9.

Phosphodiesterase 4: Rethinking cognition in Parkinson disease.

Jacova C, Factor SA.

Neurology. 2017 Aug 8;89(6):530-531. doi: 10.1212/WNL.0000000000004221. Epub 2017 Jul 12. No abstract available.

PMID:
28701498
10.

Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment.

Dao E, Best JR, Hsiung GR, Sossi V, Jacova C, Tam R, Liu-Ambrose T.

BMC Geriatr. 2017 Jun 28;17(1):133. doi: 10.1186/s12877-017-0522-4.

11.

The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer's Disease (PDC-dAD): Gauging their Validity over a Decade Later.

Sepehry AA, Lee PE, Hsiung GR, Beattie BL, Feldman HH, Jacova C.

J Alzheimers Dis. 2017;58(2):449-462. doi: 10.3233/JAD-161061. Review.

PMID:
28453472
12.

Economic evaluation of aerobic exercise training in older adults with vascular cognitive impairment: PROMoTE trial.

Davis JC, Hsiung GR, Bryan S, Best JR, Eng JJ, Munkacsy M, Cheung W, Chiu B, Jacova C, Lee P, Liu-Ambrose T.

BMJ Open. 2017 Mar 29;7(3):e014387. doi: 10.1136/bmjopen-2016-014387.

13.

Aerobic exercise and vascular cognitive impairment: A randomized controlled trial.

Liu-Ambrose T, Best JR, Davis JC, Eng JJ, Lee PE, Jacova C, Boyd LA, Brasher PM, Munkacsy M, Cheung W, Hsiung GR.

Neurology. 2016 Nov 15;87(20):2082-2090. Epub 2016 Oct 19.

14.

Erratum to: Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment.

Dao E, Hsiung GR, Sossi V, Jacova C, Tam R, Dinelle K, Best JR, Liu-Ambrose T.

BMC Neurol. 2016 Aug 31;16(1):157. No abstract available.

15.

Scientific and ethical features of English-language online tests for Alzheimer's disease.

Robillard JM, Illes J, Arcand M, Beattie BL, Hayden S, Lawrence P, McGrenere J, Reiner PB, Wittenberg D, Jacova C.

Alzheimers Dement (Amst). 2015 Jul 2;1(3):281-8. doi: 10.1016/j.dadm.2015.03.004. eCollection 2015 Sep.

16.

Agreement between Patient and Proxy Assessments of Quality of Life among Older Adults with Vascular Cognitive Impairment Using the EQ-5D-3L and ICECAP-O.

Davis JC, Hsiung GY, Bryan S, Jacova C, Jacova P, Munkacsy M, Cheung W, Lee P, Liu-Ambrose T.

PLoS One. 2016 Apr 21;11(4):e0153878. doi: 10.1371/journal.pone.0153878. eCollection 2016.

17.

Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment.

Dao E, Hsiung GY, Sossi V, Jacova C, Tam R, Dinelle K, Best JR, Liu-Ambrose T.

BMC Neurol. 2015 Oct 12;15:197. doi: 10.1186/s12883-015-0459-1. Erratum in: BMC Neurol. 2016;16(1):157.

18.

Cognitive performance following lacunar stroke in Spanish-speaking patients: results from the SPS3 trial.

Jacova C, Pearce LA, Roldan AM, Arauz A, Tapia J, Costello R, McClure LA, Hart RG, Benavente OR.

Int J Stroke. 2015 Jun;10(4):519-28. doi: 10.1111/ijs.12511.

19.

The prevalence of depressive symptoms in frontotemporal dementia: a meta-analysis.

Chakrabarty T, Sepehry AA, Jacova C, Hsiung GY.

Dement Geriatr Cogn Disord. 2015;39(5-6):257-71. doi: 10.1159/000369882. Epub 2015 Feb 4.

PMID:
25662033
20.

Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.

Pearce LA, McClure LA, Anderson DC, Jacova C, Sharma M, Hart RG, Benavente OR; SPS3 Investigators.

Lancet Neurol. 2014 Dec;13(12):1177-85. doi: 10.1016/S1474-4422(14)70224-8. Epub 2014 Oct 23.

21.

C-TOC (Cognitive Testing on Computer): investigating the usability and validity of a novel self-administered cognitive assessment tool in aging and early dementia.

Jacova C, McGrenere J, Lee HS, Wang WW, Le Huray S, Corenblith EF, Brehmer M, Tang C, Hayden S, Beattie BL, Hsiung GY.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):213-21. doi: 10.1097/WAD.0000000000000055.

PMID:
25187218
22.

Early neuropsychological characteristics of progranulin mutation carriers.

Hallam BJ, Jacova C, Hsiung GY, Wittenberg D, Sengdy P, Bouchard-Kerr P, Slack P, Rademakers R, Baker M, Chow TW, Levine B, Feldman HH, Mackenzie IR.

J Int Neuropsychol Soc. 2014 Aug;20(7):694-703. doi: 10.1017/S1355617714000551. Epub 2014 Jul 4.

PMID:
24993774
23.

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL.

Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0. Erratum in: Lancet Neurol. 2014 Aug;13(8):757.

PMID:
24849862
24.

Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia.

Chertkow H, Feldman HH, Jacova C, Massoud F.

Alzheimers Res Ther. 2013 Jul 8;5(Suppl 1):S2. doi: 10.1186/alzrt198. Epub 2013 Jul 8.

25.

Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers.

Jacova C, Hsiung GY, Tawankanjanachot I, Dinelle K, McCormick S, Gonzalez M, Lee H, Sengdy P, Bouchard-Kerr P, Baker M, Rademakers R, Sossi V, Stoessl AJ, Feldman HH, Mackenzie IR.

Neurology. 2013 Oct 8;81(15):1322-31. doi: 10.1212/WNL.0b013e3182a8237e. Epub 2013 Sep 4.

26.

A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke.

Edwards JD, Jacova C, Sepehry AA, Pratt B, Benavente OR.

Neurology. 2013 Jan 15;80(3):315-22. doi: 10.1212/WNL.0b013e31827deb85. Review.

27.

Novel surface-smoothing based local gyrification index.

Lebed E, Jacova C, Wang L, Beg MF.

IEEE Trans Med Imaging. 2013 Apr;32(4):660-9. doi: 10.1109/TMI.2012.2230640. Epub 2012 Nov 30.

PMID:
23212343
28.

Prevalence of mild cognitive impairment and its subtypes in the Mexican population.

Juarez-Cedillo T, Sanchez-Arenas R, Sanchez-Garcia S, Garcia-Peña C, Hsiung GY, Sepehry AA, Beattie BL, Jacova C.

Dement Geriatr Cogn Disord. 2012;34(5-6):271-81. doi: 10.1159/000345251. Epub 2012 Nov 29.

PMID:
23207978
29.

Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes.

Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova C.

Drugs Aging. 2012 Oct;29(10):793-806. doi: 10.1007/s40266-012-0012-5. Review.

PMID:
23079957
30.

Cognitive impairment in lacunar strokes: the SPS3 trial.

Jacova C, Pearce LA, Costello R, McClure LA, Holliday SL, Hart RG, Benavente OR.

Ann Neurol. 2012 Sep;72(3):351-62. doi: 10.1002/ana.23733.

31.

Multiple pathologies are common in Alzheimer patients in clinical trials.

Wang BW, Lu E, Mackenzie IR, Assaly M, Jacova C, Lee PE, Beattie BL, Hsiung GY.

Can J Neurol Sci. 2012 Sep;39(5):592-9.

PMID:
22931699
32.

Stay the course--is it justified?

Sepehry AA, Lee PE, Hsiung GY, Jacova C.

Lancet. 2012 Jan 21;379(9812):220. doi: 10.1016/S0140-6736(12)60102-0. No abstract available.

PMID:
22265630
33.

Revising the definition of Alzheimer's disease: a new lexicon.

Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P.

Lancet Neurol. 2010 Nov;9(11):1118-27. doi: 10.1016/S1474-4422(10)70223-4. Epub 2010 Oct 9.

PMID:
20934914
34.

Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment.

Liu-Ambrose T, Eng JJ, Boyd LA, Jacova C, Davis JC, Bryan S, Lee P, Brasher P, Hsiung GY.

BMC Neurol. 2010 Feb 17;10:14. doi: 10.1186/1471-2377-10-14.

35.

Differentiating the frontal variant of Alzheimer's disease.

Woodward M, Jacova C, Black SE, Kertesz A, Mackenzie IR, Feldman H; ACCORD investigator group.

Int J Geriatr Psychiatry. 2010 Jul;25(7):732-8. doi: 10.1002/gps.2415.

PMID:
19823987
36.

Predicting response to acetylcholinesterase inhibitor treatment in Alzheimer disease: has the time come?

Feldman HH, Jacova C.

Nat Clin Pract Neurol. 2009 Mar;5(3):128-9. doi: 10.1038/ncpneuro1007. Epub 2009 Feb 3.

PMID:
19190589
37.

Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort.

Hsiung GY, Alipour S, Jacova C, Grand J, Gauthier S, Black SE, Bouchard RW, Kertesz A, Loy-English I, Hogan DB, Rockwood K, Feldman HH.

Dement Geriatr Cogn Disord. 2008;25(6):483-90. doi: 10.1159/000126499. Epub 2008 Apr 16.

38.

Diagnosis and treatment of dementia: 2. Diagnosis.

Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, Schipper HM, Blair M, Kertesz A, Chertkow H.

CMAJ. 2008 Mar 25;178(7):825-36. doi: 10.1503/cmaj.070798. Review.

39.

Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.

Jacova C, Peters KR, Beattie BL, Wong E, Riddehough A, Foti D, Scheltens P, Li DK, Feldman HH.

Dement Geriatr Cogn Disord. 2008;25(3):238-47. doi: 10.1159/000115848. Epub 2008 Feb 8.

PMID:
18264009
40.

Neuropsychiatric symptom clusters and functional disability in cognitively-impaired-not-demented individuals.

Peters KR, Rockwood K, Black SE, Hogan DB, Gauthier SG, Loy-English I, Hsiung GY, Jacova C, Kertesz A, Feldman HH.

Am J Geriatr Psychiatry. 2008 Feb;16(2):136-44. Epub 2007 Oct 10.

PMID:
17928572
41.

Neuropsychological testing and assessment for dementia.

Jacova C, Kertesz A, Blair M, Fisk JD, Feldman HH.

Alzheimers Dement. 2007 Oct;3(4):299-317. doi: 10.1016/j.jalz.2007.07.011.

PMID:
19595951
42.

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P.

Lancet Neurol. 2007 Aug;6(8):734-46. Review.

PMID:
17616482
43.

Primary prevention and delay of onset of AD/dementia.

Feldman HH, Jacova C.

Can J Neurol Sci. 2007 Mar;34 Suppl 1:S84-9. Review.

PMID:
17469689
44.

Dropouts and refusals in observational studies: lessons for prevention trials.

Jacova C, Hsiung GY, Feldman HH.

Neurology. 2006 Nov 14;67(9 Suppl 3):S17-20.

PMID:
17101929
45.

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

Burns A, O'Brien J; BAP Dementia Consensus group, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology.

J Psychopharmacol. 2006 Nov;20(6):732-55. Review.

PMID:
17060346
46.

Mild cognitive impairment.

Feldman HH, Jacova C.

Am J Geriatr Psychiatry. 2005 Aug;13(8):645-55. Review.

PMID:
16085780
47.

Assessing mental status in dementia: the behavioral neurology assessment--right time? Right place?

Feldman HH, Jacova C.

Can J Neurol Sci. 2005 May;32(2):138-9. No abstract available.

PMID:
16018148
48.

Some pitfalls in measuring memory in animals.

Thorpe CM, Jacova C, Wilkie DM.

Neurosci Biobehav Rev. 2004 Nov;28(7):711-8. Review.

PMID:
15555680
49.

Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial.

Kremer B, Clark CM, Almqvist EW, Raymond LA, Graf P, Jacova C, Mezei M, Hardy MA, Snow B, Martin W, Hayden MR.

Neurology. 1999 Sep 22;53(5):1000-11.

PMID:
10496259
50.

Pathological association and dissociation of functional systems in multiple sclerosis and Huntington's disease.

Clark CM, Jacova C, Klonoff H, Kremer B, Hayden M, Paty D.

J Clin Exp Neuropsychol. 1997 Feb;19(1):63-76.

PMID:
9071642

Supplemental Content

Loading ...
Support Center